Abstract
HPR184 Social Determinants of Health (SDoH) and Other Predictors in Treatment Initiation with CDK4/6 Inhibitors in Medicare Patients with HR+/HER2– Metastatic Breast Cancer (MBC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have